Bernstein Harold Insider Trades & Stock Holdings

President, R&D & CMO · Maze Therapeutics, Inc. · Latest filing Oct 1, 2026

Bernstein Harold, President, R&D & CMO at Maze Therapeutics, Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($434.74K), net -$434.74K. Latest filing: disposed of 16.14K shares of $MAZE on Oct 1, 2026 at $26.93.

Trades on file

1

Open-market bought

$0

Open-market sold

$434.74K

Net open-market

-$434.74K

Latest filing

Oct 1, 2026

All insider trades by Bernstein Harold

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$MAZE	Sell (Open-market sale) 10b5-1	16.14K	$26.93	$434.74K			-2.9%			President, R&D & CMO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Bernstein Harold traded

• $MAZE

Frequently asked questions

Has Bernstein Harold been buying or selling stock?

Bernstein Harold has 0 open-market purchases and 1 open-market sale on file, net -$434.74K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Bernstein Harold's latest insider trade?

disposed of 16.14K shares of $MAZE on Oct 1, 2026 at $26.93.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.